Keyword: Boston

After its acquisitions of gene and cell therapy players Exonics and Semma, Vertex is looking to lease 256,000 square feet of space near its Boston HQ.

When Sanofi inked a massive lease in Cambridge Crossing last year, the drugmaker found itself in prime position for another real estate deal.

Sanofi has picked the spot for its Massachusetts HQ, once again planting its flag squarely in the epicenter of biotech on the East Coast.

Genzyme is reportedly looking for 400,000 square feet of space near its headquarters, hoping to gather scattered operations and secure room to grow.

Takeda plans to shutter its Chicago-area U.S. headquarters and open a site somewhere in Boston after closing its Shire deal.

Letters from patients to scientists anchor a new Pfizer-sponsored content campaign with the Boston Globe’s BG BrandLab.

Following a sales fraud investigation that led to major executive changes, Alexion’s new management is rolling out its first corporate revamp.

Specialists at rare disease drug launches, Cambridge BioMarketing was snapped up by an expansion-minded healthcare services firm, Ireland's UDG.

Hundreds of Takeda employees in R&D and vaccines have relocated from suburban Chicago to the Boston area, according to a new report.

Biopharma and Boston banter blankets the Kendall Square subway station—make that the “T” station—this month thanks to pharma services company Precision Medicine Group.